Clinical trial / 2017
Neither vitamin E nor selenium supplementation, alone or combined, prevented dementia in older men.
The PREADViSE trial evaluated whether vitamin E, selenium, or their combination could prevent dementia in asymptomatic older men, starting as a randomized clinical trial and continuing as a cohort study. Across 7338 analyzed men, dementia incidence was 4.4% (325 cases) and did not differ among the study arms. Adjusted hazard ratios compared with placebo were 0.88 (95% CI, 0.64-1.20) for vitamin E, 0.83 (95% CI, 0.60-1.13) for selenium, and 1.00 (95% CI, 0.75-1.35) for the combination.
- Study type
- Randomized clinical trial transformed into a cohort study
- Who was studied
- 7540 asymptomatic men at least 60 years old (mean age 67.5 years)
- What was measured
- Incidence of dementia
THE PAPER
Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE).
Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, Yee M, Crowley J, Schmitt FA. JAMA Neurol, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.